Literature DB >> 989736

Factors determining the potency of mydriatic drugs in man.

S A Smith.   

Abstract

1 The mydriasis resulting from topical application of five atropine-like drugs was measured photographically in man. Drug potency was obtained from log dose-response curves. 2 The in vitro potency of eight cholinoceptor blocking drugs, including those studied in man, was obtained by measuring their affinity constants for binding to the receptors of an isolated preparation of the rabbit sphincter pupillae. Values agreed closely with those obtained for the muscarinic receptors of guinea-pig ileum. 3 In vitro and in vivo potency was compared to obtain a quantitative measure of the relative ease with which drugs gain access to the receptors after topical application. 4 The large differences that occur in the intensity and duration of the mydriatic response to atropine-like drugs is primarily the result of differences in their ability to blcok the receptors. Only with tropicamide does its relatively high accessibility affect its potency in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989736      PMCID: PMC2958753          DOI: 10.1111/j.1365-2125.1976.tb00628.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Drug antagonism and pAx.

Authors:  H O SCHILD
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

2.  On the cooperativity of biological membranes.

Authors:  J P Changeux; J Thiéry; Y Tung; C Kittel
Journal:  Proc Natl Acad Sci U S A       Date:  1967-02       Impact factor: 11.205

3.  Unequal accumulation of adrenergic drugs by pigmented and nonpigmented iris.

Authors:  P M Patil; D Jacobowitz
Journal:  Am J Ophthalmol       Date:  1974-09       Impact factor: 5.258

4.  Adrenergic blockade and the eye signs of thyrotoxicosis.

Authors:  J M Sneddon; P Turner
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

5.  Mydriatic drugs for routine fundal inspection. A reappraisal.

Authors:  S E Smith
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

6.  Pilocarpine uptake by pigmented uveal tissue.

Authors:  J S Lyons; D L Krohn
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

7.  Accumulation of (-)-14C-ephedrine by the pigmented and the nonpigmented iris.

Authors:  P N Patil; K Shimada; D R Feller; L Malspeis
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

8.  Cocaine-binding by the pigmented and the nonpigmented iris and its relevance to the mydriatic effect.

Authors:  P N Patil
Journal:  Invest Ophthalmol       Date:  1972-09

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  A comparison of the affinities of antagonists for acetylcholine receptors in the ileum, bronchial muscle and iris of the guinea-pig.

Authors:  R B Barlow; F M Franks; J D Pearson
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

View more
  6 in total

1.  A pharmacological method for measuring the penetration of topical mydriatic drugs in man.

Authors:  F Nicholson; K L Clark; S J Brecker; S A Smith
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

2.  Receptor-responses in fresh human ciliary muscle.

Authors:  M D Lograno; A Reibaldi
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

Review 3.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

4.  The affinity of atropine for muscarine receptors in human sphincter pupillae.

Authors:  A J Kaumann; R Hennekes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

5.  Plasma concentrations and ocular effects of cyclopentolate after ocular application of three formulations.

Authors:  K Lahdes; R Huupponen; T Kaila; D Monti; M F Saettone; L Salminen
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

6.  The effect of topical atropine on the choroidal thickness of healthy children.

Authors:  Zhengwei Zhang; Yuanting Zhou; Zhifang Xie; Tiantian Chen; Yan Gu; Shui Lu; Zhifeng Wu
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.